pta20251229015
Managers' transactions announcement according to article 19 MAR

Vidac Pharma Holding PLC: Correction of a Managers' transactions announcement according to article 19 MAR from 18.12.2025

London (pta015/29.12.2025/15:51 UTC+1) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr Max Herzberg
2 Reason for the notification
a) Position/status Member of the managing body
b) Amendment Correction of the publication dated 18 December 2025, in which transactions on two trading venues were combined.
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Vidac Pharma Holding PLC
b) LEI 875500BCH1T6XX5EUG13
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
  Identification code GB00BM9XQ619
b) Nature of the transaction Sale
c) Price(s) Volume(s)
  0.54 EUR 18,900.00 EUR
  0.54 EUR 27,000.00 EUR
d) Aggregated price Aggregated volume
  0.54 EUR 45,900.00 EUR
e) Date of the transaction 15.12.2025 UTC+1
f) Place of the transaction Open Market Stuttgart Stock Exchange
  MIC XSTU

(end)

Emitter: Vidac Pharma Holding PLC
20-22 Wenlock Road
N1 7GU London
United Kingdom
Contact Person: Sandra Gamzon
Phone: +972 544 999951
E-Mail: investors@vidacpharma.com
Website: www.vidacpharma.com
ISIN(s): GB00BM9XQ619 (Share)
Stock Exchange(s): Free Market in Berlin, Dusseldorf (Primärmarkt), Hamburg, Stuttgart
|